Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1974-10-4
pubmed:abstractText
Immunocompetence was followed serially for 1 yr from the onset of treatment in 55 adult patients with acute leukemia. The tests used were delayed hypersensitivity responses to a battery of five recall antigens (dermatophytin, dermatophytin 0, candida, streptokinase-streptodornase, and mumps) and in vitro lymphocyte blastogenic responses to phytohemagglutinin and streptolysin 0. There was a strong correlation between immunocompetence at the start of treatment and a good prognosis; 32/39 patients who subsequently entered remission were initially immunocompetent compared to 4/15 who failed to enter remission. In the complete remission group there was a decline in competence starting from 2 to 5 mo after the onset of treatment. In those who remained in remission for 1 yr, competence recovered at 6 mo and remained vigorous thereafter. In those who relapsed before 1 yr, the decline in competence occurred 1 mo before relapse and competence continued to decline progressively during the 1 yr follow-up period. These studies suggest that therapeutic approaches which restore immunocompetence or prevent its decline will improve both the remission rate and the remission duration of patients with acute leukemia.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/4527189-14332475, http://linkedlifedata.com/resource/pubmed/commentcorrection/4527189-4116319, http://linkedlifedata.com/resource/pubmed/commentcorrection/4527189-4182654, http://linkedlifedata.com/resource/pubmed/commentcorrection/4527189-4354467, http://linkedlifedata.com/resource/pubmed/commentcorrection/4527189-4513355, http://linkedlifedata.com/resource/pubmed/commentcorrection/4527189-4565852, http://linkedlifedata.com/resource/pubmed/commentcorrection/4527189-4582620, http://linkedlifedata.com/resource/pubmed/commentcorrection/4527189-4708150, http://linkedlifedata.com/resource/pubmed/commentcorrection/4527189-4708575, http://linkedlifedata.com/resource/pubmed/commentcorrection/4527189-4921480, http://linkedlifedata.com/resource/pubmed/commentcorrection/4527189-5286447, http://linkedlifedata.com/resource/pubmed/commentcorrection/4527189-5286519, http://linkedlifedata.com/resource/pubmed/commentcorrection/4527189-5413507, http://linkedlifedata.com/resource/pubmed/commentcorrection/4527189-5447018, http://linkedlifedata.com/resource/pubmed/commentcorrection/4527189-5790283, http://linkedlifedata.com/resource/pubmed/commentcorrection/4527189-5844228
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0021-9738
pubmed:author
pubmed:issnType
Print
pubmed:volume
54
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
401-8
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed-meshheading:4527189-Adolescent, pubmed-meshheading:4527189-Adult, pubmed-meshheading:4527189-Aged, pubmed-meshheading:4527189-Antibody Formation, pubmed-meshheading:4527189-Antineoplastic Agents, pubmed-meshheading:4527189-Cyclophosphamide, pubmed-meshheading:4527189-Cytarabine, pubmed-meshheading:4527189-Drug Therapy, Combination, pubmed-meshheading:4527189-Follow-Up Studies, pubmed-meshheading:4527189-Humans, pubmed-meshheading:4527189-Hypersensitivity, Delayed, pubmed-meshheading:4527189-Immunotherapy, pubmed-meshheading:4527189-Lectins, pubmed-meshheading:4527189-Leukemia, pubmed-meshheading:4527189-Leukemia, Lymphoid, pubmed-meshheading:4527189-Leukemia, Myeloid, Acute, pubmed-meshheading:4527189-Lymphocyte Activation, pubmed-meshheading:4527189-Lymphocytes, pubmed-meshheading:4527189-Middle Aged, pubmed-meshheading:4527189-Prednisone, pubmed-meshheading:4527189-Prognosis, pubmed-meshheading:4527189-Remission, Spontaneous, pubmed-meshheading:4527189-Skin Tests, pubmed-meshheading:4527189-Streptolysins, pubmed-meshheading:4527189-Vincristine
pubmed:year
1974
pubmed:articleTitle
Serial studies of immunocompetence of patients undergoing chemotherapy for acute leukemia.
pubmed:publicationType
Journal Article, In Vitro